Colin Blackmore
Platform Lead, Augmented Dmta @AstraZeneca
Signup · Get unlimited contacts
WORK HISTORY
Platform Lead, Augmented Dmta @AstraZeneca
Cambridge, GB
Leading the global Augmented-DMTA team of engineers, informaticians, BAs supporting 60+ applications used across Drug Discovery.
EDUCATION
University of Liverpool
Wellcome Trust PhD, Physiology
University of Cambridge
MA, Natural Sciences (Biological)
SKILLS
ABOUT COLIN BLACKMORE
We have recently joined our Augmented Drug Design and Make-Test and Analyse DevOps teams into a single groups focused on supporting AZ scientists accelerating AZ small molecule and new modality drug discovery. We are currently seeking top engineering talent to build on an award-winning Augmented Design platform to further modernise our Drug Discovery toolsets and provide best-in-industry user experiences for our scientists. Currently I lead this team of engineers, informaticians and BAs building, modernising and supporting a wide range of DMTA software applications in our mission to accelerate Drug Discovery. SpecialitiesLife Sciences, Drug Discovery, Business Partnering, Analytics, Data Discovery, Data Visualisation, Clinical Data Analysis, Sales and Marketing analytics, HR Analytics, Life Sciences Research, Technical Pre-Sales, Product Management, Product Development and launch, Supply Chain, Business Intelligence, Image Analysis.IndustriesPharmaceuticals, Contract Research Organisations, Academia, Healthcare, Consumer Packaged Goods, Retail, Technology, Software, Scientific Instruments & Reagents
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.